Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director comp.
Acq. announced
Appointed director
Notes underwriting agrmnt

MedTech Acquisition Corp Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "STANDBY EQUITY PURCHASE AGREEMENT"
08/16/2023 8-K Director compensation was amended/approved, Acquisition/merger/asset purchase announced
Docs: "Second Amended and Restated Certificate of Incorporation of TriSalus Life Sciences, Inc",
"Amended and Restated Bylaws of TriSalus Life Sciences, Inc",
"Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock of TriSalus Life Sciences, Inc",
"Specimen Common Stock Certificate",
"Specimen Warrant Certificate",
"Description of Common Stock",
"April 5, 2023",
"April 5, 2023",
"April 5, 2023",
"April 5, 2023"
08/09/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
08/02/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
Docs: "MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders"
08/02/2023 8-K Quarterly results
07/21/2023 8-K Quarterly results
07/06/2023 8-K Entered into an underwriting agreement for the issuance and sale of notes
Docs: "THIRD Amendment To Agreement AND PLAN OF MERGER THIS THIRD AMENDMENT TO AGREEMENT AND PLAN OF MERGER , dated as of July 5, 2023, is made and entered into by and among MedTech Acquisition Corporation, a Delaware corporation , MTAC Merger Sub, Inc., a Delaware corporation and direct, wholly owned subsidiary of Acquiror , and TriSalus Life Sciences, Inc., a Delaware corporation . Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Merger Agreement . RECITALS A. WHEREAS, Acquiror, Merger Sub and the Company are parties to that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended pursuant to that certain First Amendment to Agreement and Plan of Merger, dated as of April 4, 2023 and Second Amendment to Agreement and P...",
"SUBSCRIPTION AGREEMENT",
"Letter re: Termination of Backstop Letter Agreement"
06/30/2023 8-K Unregistered Sales of Equity Securities  Interactive Data
06/12/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting",
"TriSalus Corporate Twitter Post We introduced new clinical data at the #ASCO23 Annual Meeting, supporting our hypothesis that SD-101 delivered via TriNav™ using PEDD™ may have favorable immune effects both within the liver and systemically. Learn more: https://trisaluslifesci.com//recent-news/trisalus-life-sciences-presents-additional-data-for-sd-101-delivered-by-the-proprietary-pedd-method-with-the-trinav-device-for-uveal-melanoma-liver-metastases-at-the-asco-2023-annual/ TriSalus Corporate LinkedIn Post"
06/08/2023 8-K Entered into an underwriting agreement for the issuance and sale of notes
Docs: "Form of Subscription Agreement",
"Backstop Letter Agreement, by and between MedTech Acquisition Corporation and MedTech Acquisition Sponsor LLC"
05/15/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Second Amendment to Agreement and Plan of Merger, by and among MedTech Acquisition Corporation, MTAC Merger Sub, Inc., and TriSalus Life Sciences, Inc"
04/20/2023 8-K Quarterly results
04/05/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "First Amendment to Agreement and Plan of Merger, by and among MedTech Acquisition Corporation, MTAC Merger Sub, Inc., and TriSalus Life Sciences, Inc"
03/08/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Amendment No. 1 to Term Sheet, by and among MedTech Acquisition Corporation, TriSalus Life Sciences, Inc. and Magnetar Capital LLC"
12/21/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "TriSalus Video Transcript Text on screen: Dr. Carvajal is a Member of the TriSalus Scientific Advisory Board and Investigator for the PERIO-01study. My name is Rich Carvajal. I’ m a medical Oncologist at Columbia University Irving Medical Center where I oversee the melanoma program as well as the experimental therapeutics program. Text on screen: What Are the Challenges in Trying to Find a Cure for Liver Cancer? Well cancers that go to the liver are extremely challenging to treat. You know, if we look at any cancer – whether it’ s pancreatic cancer, colon cancer, uveal melanoma, skin melanoma – if it goes to the liver, it is invariably harder to treat. Overall survival that we see in these patients is inferior to patients who don’ t have liver disease. Text on screen: How Does TriSalus Try...",
"TriSalus Corporate Twitter Post Listen to Dr. Richard Carvajal, member of our scientific advisory board and investigator on the PERIO™-01 #clinicaltrial, discuss challenges of treating #livercancer, our investigational platform, and early findings from the PERIO™ trials below👇 https://youtu.be/zvgCMqUcZ-M TriSalus Corporate LinkedIn Post Listen to Dr. @Richard Carvajal, member of our scientific advisory board and investigator on the PERIO™-01 #clinicaltrial, discuss the challenges of treating #livercancer, what makes our investigational platform unique, and early findings from the ongoing PERIO TM clinical trials below 👇 https://youtu.be/zvgCMqUcZ-M"
12/16/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amendment to Amended and Restated Certificate of Incorporation",
"Promissory Note issued to MedTech Acquisition Sponsor LLC",
"Promissory Note issued to MedTech Acquisition Sponsor LLC"
12/15/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "TriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ Clinical Trial Progress and Pre-clinical Research Developments"
12/07/2022 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
Docs: "The Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting."
12/02/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "AMENDMENT NO. 1 TO PROMISSORY NOTE Dated as of December [•], 2022 Principal Amount: Up to $[●] New York, New York MedTech Acquisition Corporation, a Delaware corporation , hereby amends its promissory note, dated as of [●] , effective as of the date hereof, to delete and replace Section 1 of the Original Note in its entirety with the following: 1. Principal . The Payee shall be obligated to lend to the Maker amounts up to the Maximum Principal Amount. The principal balance of this Note, as reflected on Schedule A hereto , shall be repayable on the date on which the Maker consummates a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses . No amount shall be due under this Note if such Initi..."
11/21/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact:",
"Social Media Posts"
05/26/2022 8-K Quarterly results
03/10/2022 8-K Quarterly results
03/07/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/23/2022 8-K Quarterly results
01/28/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Schedule A"
12/30/2021 8-K Quarterly results
12/09/2021 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review &nbsp...
08/13/2021 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Business Combination Agreement, by among MedTech Acquisition Corp., Memic Innovative Surgery Ltd., and Maestro Merger Sub, Inc",
"Sponsor Letter Agreement",
"Form of Memic Voting Agreement",
"Confidentiality and Lock-Up Agreement, by and among Memic Innovative Surgery Ltd., MedTech Acquisition Corp., MedTech Acquisition Sponsor LLC and the other parties named therein",
"Form of Registration Rights Agreement",
"Form of PIPE Subscription Agreement",
"Investor Contact:",
"Investor Presentation",
"Script for August 13, 2021 Investor Call"
06/03/2021 8-K Quarterly results
06/02/2021 8-K Quarterly results
05/03/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/22/2021 8-K Quarterly results
02/05/2021 8-K Quarterly results
12/30/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Audited Balance Sheet as of December 22, 2020"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy